Which drugs does patent 6,514,953 protect, and when does it expire?
Patent 6,514,953 protects LEXIVA and is included in one NDA. There has been one Paragraph IV challenge on Lexiva.
Protection for LEXIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-four patent family members in forty-six countries.